Key result
Day-care IV furosemide relieves breathlessness and avoids hospitalization in ~94% of chronic heart failure patients.
Why the study?
Fluid overload is a common manifestation of decompensated chronic heart failure and the effectiveness of intravenous diuretic treatment in a day-care setting needed investigation.
Does intravenous furosemide administered in a day-care setting improve symptoms and prevent hospital admission in patients with fluid overload and chronic heart failure?
Does intravenous furosemide administered in a day-care setting improve symptoms and prevent hospital admission in patients with fluid overload and chronic heart failure?
Intravenous furosemide administered in a day-care setting over three days is safe, improves symptoms, and reduces the need for hospital admissions in patients with decompensated heart failure.
May support day-care IV furosemide for symptom relief and admission avoidance in decompensated HF; hypothesis-generating and requires RCT confirmation.
Fluid overload is a common manifestation of decompensated chronic heart failure. This paper reports on a pilot study that investigated whether intravenous (i.v.) furosemide administered on a cardiology day ward for three successive days was effective in improving the symptoms of patients with fluid overload and chronic heart failure. The results showed that 94.1% of patients reported an improvement in their breathlessness, with a marked weight loss in 88.2% of patients. There were no marked changes in blood pressure or renal function. Hospital admission was avoided in 94.1% of cases. The study concluded that i.v. diuretic treatment given in a hospital day-care setting is safe and effective, and that it reduces the need for hospital admissions. As a consequence, this reduces the associated financial costs of hospitalisation.
No takes yet. Share an insight, caveat, or question.
Banerjee et al. (2012) studied Fluid overload and chronic heart failure. Intravenous (i.v.) furosemide was evaluated on Improvement in breathlessness. Intravenous furosemide administered in a day-care setting improved breathlessness and avoided hospital admission in 94.1% of patients with fluid overload and chronic heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: